Ацетилсалициловая кислота 500 мг таблетки

Land: Kirgisistan

Språk: russisk

Kilde: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Aktiv ingrediens:

Ацетилсалициловая кислота

Tilgjengelig fra:

ОАО "Борисовский завод медицинских препаратов" (ОАО "Борисовский завод медицинских препаратов")

ATC-kode:

N02BA01

INN (International Name):

Acetylsalicylic acid

Dosering :

500 мг

Legemiddelform:

таблетки

Enheter i pakken:

№10 (стрип)

Resept typen:

без рецепта

Produsert av:

ОАО "Борисовский завод медицинских препаратов" (Беларусь)

Produkt oppsummering:

ПЖВЛС: да

Autorisasjon dato:

2019-12-13

Preparatomtale

Krt
fixanroPorona
n-ru>
r,rHCrPyKUlIfl
IIoMEAI4Uu".*fl#IXIUIVIEHEHIII0JIEKAPCTBBHHOI
o
AUETI,II
C
AJIIIUUJIOBA-fl
KII
C
JIOTA
Topronoe
Ha3BaHIre
AuerulcalullllnoBafl
KI'IcJlora.
MexgyuapoAHoe
HerIareHToBaHHoe
HaIrMeHoBaHue
Acetylsalicylic
acid.
JlenapcrneHHafl
QoPua
Ta6nerru.
Onucauue
Ta6nerxu
6euoro
IIBera,
cJlertta
MpttMopHble,
[nocKoII[nI,IHApuqecKI'Ie,
c
pLIcKofi
,
(p
acroft
.
vTBEP}KAAIO
3avrecrureJrb
AITPeKToPa
,flenapraueuTa
JreKapcrBeHuoro
o6ecneqeulrr
rr
MeArrrlnncrcofi
TexHrrKIr
MuuucrePcrBa
3,[PaBooxPaHeHHq
2019r.
xapaKTepHbIM
3alaxoM,
Cocran
O.qua
ra6lerxa
coAepxr,rr:
deilcmaynt4ezo
6et4ecmla
-
aqerl,IJlcaJluqurosofi
KI{cJIorbI
-
500
Mt;
7cnol1o?qmerbHbte
6eu4ecmaa:
raptotfelrnrrft
KpzxMaJI,
KlrcJlora
JII'IMoHHtUI
uuueBilI,
TaJrbK,
KLIcJIoTa
cTeapLIHoBaJI,
KpeMHIlfl
AuoKcIlA
KoJIJIoI'IAHbIfi
6egnoAnrtft
.
OaprvraxorepareBT[qecKafl
rpyflrra
Asalrreruru.
Anansrerr,rKr.r
-
aHTr.rrrHperHKI,I
Apyr[e.
Canuqulonarl
KI'IcJIora
I'I
[poI'I3BoAHbIe.
AuerurcaruulrJloBtul
Kllcrora.
Koa
ATX:
N02BA01.
(Dapuarco.uoruqecr[e
cBofi
crBa
(Dapnaxoduw(MuKa
Aqetruca.nuur,rJroBtu
KlIcJroTa
oKitilbrBaer
rIporI,IBoBoctIaJII,ITeJIbHoe,
aHaJlbre3[Ipyloqee,
xapofloHl{xarcqee
u
aHT}IarperaIIrIoHHoe
Aeft
crsfie.
Mexanugpr
[efiCrsus,cB.f,3aH
c
ueo6paruusru
unru6r4poBaHl,IeM
aKT]IBHocrI{
III4KJIooKcureHasH
I
u
II
runos
rlyreM
ee
aIrerI,IJIIrpoBaHlIfl.
Aqerulcal[qr,rJroBiur
Kl{cJrora
yMeHburaer
rI,IlepeMI{Io,
SKccyAaIIruo
Lt
[poHlrllaeMocrb
Kau.rJrJtflpoB
B
orrare
BocrraJreHlrx.
Topivtosur
aKTuBuocrb
rllaflypoHrlAa3bl,
ylHeraer
flpoAyKll]lrc
ATO,
orpaHr,rqr,rBrur
gHeprerr,rqecKoe
o6ecueqesrle
BocIItu[TeJIbHoro
[pollgcca.
Aqeutncallrql,IJloBarr
Kl,rcJrora
B
rrepopaJlbublx
Ao3ax,
KaK
IIpaBlIJIo,
ot
0,3
r
Ao
1,0
I
lrcrroJrb3yercfl
Ailfl,
o6rer.reHus
6onu
u
rtpll
yMgpeHHo
BbIpDKeHHbIx
rllxopaAoqHbx
cocTorHr.rsx,
xapaKTepHbrx
AJu
npocTyAbr
UJII,I
rpflIlfla,
a
TaKxe
AJI'
oH]IXeHI'IS
TeMUepaTypbI
]I
o6rerqeHr,rs
Sonu
B
cycraBax
r.r
Mbrrlqax.
Irlcuomsyercfl
TaKxe
rIpH ocrpbrx
u
xpoHHqecKEx
BocrrarJrr.rreJrbHbrx
3a6olenauuxx,
TaKlrx
KaK
penuat